Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Orally Disintegrating Tablet Market Report for Period 2018 till 2024

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

Scope of the Report:
This report focuses on the Orally Disintegrating Tablet in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Anti-Psychotics Drug
Anti-Epileptics Drug
Other

Market Segment by Applications, can be divided into
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other

There are 15 Chapters to deeply display the global Orally Disintegrating Tablet market.

Chapter 1, to describe Orally Disintegrating Tablet Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Orally Disintegrating Tablet, with sales, revenue, and price of Orally Disintegrating Tablet, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Orally Disintegrating Tablet, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Orally Disintegrating Tablet market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Orally Disintegrating Tablet sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Orally Disintegrating Tablet Introduction
1.2 Market Analysis by Type
1.2.1 Anti-Psychotics Drug
1.2.2 Anti-Epileptics Drug
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 CNS Diseases
1.3.2 Gastrointestinal Diseases
1.3.3 CVS Diseases
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market Status and Outlook (2013-2023)
1.4.1.2 Canada Market Status and Outlook (2013-2023)
1.4.1.3 Mexico Market Status and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market Status and Outlook (2013-2023)
1.4.2.2 France Market Status and Outlook (2013-2023)
1.4.2.3 UK Market Status and Outlook (2013-2023)
1.4.2.4 Russia Market Status and Outlook (2013-2023)
1.4.2.5 Italy Market Status and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market Status and Outlook (2013-2023)
1.4.3.2 Japan Market Status and Outlook (2013-2023)
1.4.3.3 Korea Market Status and Outlook (2013-2023)
1.4.3.4 India Market Status and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market Status and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market Status and Outlook (2013-2023)
1.4.4.2 Egypt Market Status and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market Status and Outlook (2013-2023)
1.4.4.4 South Africa Market Status and Outlook (2013-2023)
1.4.4.5 Nigeria Market Status and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Orally Disintegrating Tablet Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Teva Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Orally Disintegrating Tablet Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merck Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Orally Disintegrating Tablet Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Mylan Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Orally Disintegrating Tablet Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Pfizer Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson and Johnson
2.5.1 Business Overview
2.5.2 Orally Disintegrating Tablet Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GSK
2.6.1 Business Overview
2.6.2 Orally Disintegrating Tablet Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 GSK Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Otsuka
2.7.1 Business Overview
2.7.2 Orally Disintegrating Tablet Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Otsuka Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eli Lilly and Company
2.8.1 Business Overview
2.8.2 Orally Disintegrating Tablet Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AstraZeneca
2.9.1 Business Overview
2.9.2 Orally Disintegrating Tablet Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bristol-Myers Squibb
2.10.1 Business Overview
2.10.2 Orally Disintegrating Tablet Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Conquer
2.11.1 Business Overview
2.11.2 Orally Disintegrating Tablet Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Conquer Orally Disintegrating Tablet Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Orally Disintegrating Tablet Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Orally Disintegrating Tablet Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Orally Disintegrating Tablet Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Orally Disintegrating Tablet Manufacturer Market Share
3.3.2 Top 6 Orally Disintegrating Tablet Manufacturer Market Share
3.4 Market Competition Trend
4 Global Orally Disintegrating Tablet Market Analysis by Regions
4.1 Global Orally Disintegrating Tablet Sales, Revenue and Market Share by Regions
4.1.1 Global Orally Disintegrating Tablet Sales and Market Share by Regions (2013-2018)
4.1.2 Global Orally Disintegrating Tablet Revenue and Market Share by Regions (2013-2018)
4.2 North America Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
4.3 Europe Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
4.5 South America Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
5 North America Orally Disintegrating Tablet by Countries
5.1 North America Orally Disintegrating Tablet Sales, Revenue and Market Share by Countries
5.1.1 North America Orally Disintegrating Tablet Sales and Market Share by Countries (2013-2018)
5.1.2 North America Orally Disintegrating Tablet Revenue and Market Share by Countries (2013-2018)
5.2 United States Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
5.3 Canada Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
5.4 Mexico Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
6 Europe Orally Disintegrating Tablet by Countries
6.1 Europe Orally Disintegrating Tablet Sales, Revenue and Market Share by Countries
6.1.1 Europe Orally Disintegrating Tablet Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Orally Disintegrating Tablet Revenue and Market Share by Countries (2013-2018)
6.2 Germany Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
6.3 UK Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
6.4 France Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
6.5 Russia Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
6.6 Italy Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
7 Asia-Pacific Orally Disintegrating Tablet by Countries
7.1 Asia-Pacific Orally Disintegrating Tablet Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Orally Disintegrating Tablet Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Orally Disintegrating Tablet Revenue and Market Share by Countries (2013-2018)
7.2 China Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
7.3 Japan Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
7.4 Korea Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
7.5 India Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
8 South America Orally Disintegrating Tablet by Countries
8.1 South America Orally Disintegrating Tablet Sales, Revenue and Market Share by Countries
8.1.1 South America Orally Disintegrating Tablet Sales and Market Share by Countries (2013-2018)
8.1.2 South America Orally Disintegrating Tablet Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
8.3 Argentina Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
8.4 Colombia Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
9 Middle East and Africa Orally Disintegrating Tablet by Countries
9.1 Middle East and Africa Orally Disintegrating Tablet Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Orally Disintegrating Tablet Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Orally Disintegrating Tablet Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
9.3 UAE Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
9.4 Egypt Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
9.5 Nigeria Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
9.6 South Africa Orally Disintegrating Tablet Sales and Growth Rate (2013-2018)
10 Global Orally Disintegrating Tablet Market Segment by Type
10.1 Global Orally Disintegrating Tablet Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Orally Disintegrating Tablet Sales and Market Share by Type (2013-2018)
10.1.2 Global Orally Disintegrating Tablet Revenue and Market Share by Type (2013-2018)
10.2 Anti-Psychotics Drug Sales Growth and Price
10.2.1 Global Anti-Psychotics Drug Sales Growth (2013-2018)
10.2.2 Global Anti-Psychotics Drug Price (2013-2018)
10.3 Anti-Epileptics Drug Sales Growth and Price
10.3.1 Global Anti-Epileptics Drug Sales Growth (2013-2018)
10.3.2 Global Anti-Epileptics Drug Price (2013-2018)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2013-2018)
10.4.2 Global Other Price (2013-2018)
11 Global Orally Disintegrating Tablet Market Segment by Application
11.1 Global Orally Disintegrating Tablet Sales Market Share by Application (2013-2018)
11.2 CNS Diseases Sales Growth (2013-2018)
11.3 Gastrointestinal Diseases Sales Growth (2013-2018)
11.4 CVS Diseases Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Orally Disintegrating Tablet Market Forecast (2018-2023)
12.1 Global Orally Disintegrating Tablet Sales, Revenue and Growth Rate (2018-2023)
12.2 Orally Disintegrating Tablet Market Forecast by Regions (2018-2023)
12.2.1 North America Orally Disintegrating Tablet Market Forecast (2018-2023)
12.2.2 Europe Orally Disintegrating Tablet Market Forecast (2018-2023)
12.2.3 Asia-Pacific Orally Disintegrating Tablet Market Forecast (2018-2023)
12.2.4 South America Orally Disintegrating Tablet Market Forecast (2018-2023)
12.2.5 Middle East and Africa Orally Disintegrating Tablet Market Forecast (2018-2023)
12.3 Orally Disintegrating Tablet Market Forecast by Type (2018-2023)
12.3.1 Global Orally Disintegrating Tablet Sales Forecast by Type (2018-2023)
12.3.2 Global Orally Disintegrating Tablet Market Share Forecast by Type (2018-2023)
12.4 Orally Disintegrating Tablet Market Forecast by Application (2018-2023)
12.4.1 Global Orally Disintegrating Tablet Sales Forecast by Application (2018-2023)
12.4.2 Global Orally Disintegrating Tablet Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 24 hours.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 38155

Category: 11

Published date: 2018-03-25 14:19:33

Number of Pages: 102

Publisher Name: GIR

Over all Rating: 96 % (Average of Ratings provided by clients)